Kaliyadan Antony G, Chawla Harnish, Fischman David L, Ruggiero Nicholas, Gannon Michael, Walinsky Paul, Savage Michael P
Jefferson Angioplasty Center, Thomas Jefferson University Hospital, 111 South 11th Street, Gibbon Building, Suite 6210, Philadelphia, PA 19107 USA.
J Invasive Cardiol. 2017 Feb;29(2):54-58. Epub 2016 Dec 15.
This study assessed the impact of adjunct delivery techniques on the deployment success of distal protection filters in saphenous vein grafts (SVGs).
Despite their proven clinical benefit, distal protection devices are underutilized in SVG interventions. Deployment of distal protection filters can be technically challenging in the presence of complex anatomy. Techniques that facilitate the delivery success of these devices could potentially improve clinical outcomes and promote greater use of distal protection.
Outcomes of 105 consecutive SVG interventions with attempted use of a FilterWire distal protection device (Boston Scientific) were reviewed. In patients in whom filter delivery initially failed, the success of attempted redeployment using adjunct delivery techniques was assessed. Two strategies were utilized sequentially: (1) a 0.014" moderate-stiffness hydrophilic guidewire was placed first to function as a parallel buddy wire to support subsequent FilterWire crossing; and (2) if the buddy-wire approach failed, predilation with a 2.0 mm balloon at low pressure was performed followed by reattempted filter delivery.
The study population consisted of 80 men and 25 women aged 73 ± 10 years. Mean SVG age was 14 ± 6 years. Complex disease (American College of Cardiology/American Heart Association class B2 or C) was present in 92%. Initial delivery of the FilterWire was successful in 82/105 patients (78.1%). Of the 23 patients with initial failed delivery, 8 (35%) had successful deployment with a buddy wire alone, 7 (30%) had successful deployment with balloon predilation plus buddy wire, 4 (17%) had failed reattempt at deployment despite adjunct maneuvers, and in 4 (17%) no additional attempts at deployment were made at the operator's discretion. Deployment failure was reduced from 21.9% initially to 7.6% after use of adjunct delivery techniques (P<.01). No adverse events were observed with these measures.
Deployment of distal protection devices can be technically difficult with complex SVG disease. Adjunct delivery techniques are important to optimize deployment success of distal protection filters during SVG intervention.
本研究评估辅助输送技术对大隐静脉旁路移植血管(SVG)中远端保护滤器置入成功率的影响。
尽管远端保护装置已被证实具有临床益处,但在SVG介入治疗中其应用仍不充分。在存在复杂解剖结构的情况下,置入远端保护滤器在技术上可能具有挑战性。有助于这些装置成功输送的技术可能会改善临床结局并促进远端保护的更多应用。
回顾了105例连续的SVG介入治疗病例,这些病例尝试使用FilterWire远端保护装置(波士顿科学公司)。对于最初滤器输送失败的患者,评估使用辅助输送技术再次尝试置入成功的情况。依次采用了两种策略:(1)首先置入一根0.014英寸的中等硬度亲水导丝作为平行导丝,以支持随后的FilterWire通过;(2)如果导丝辅助方法失败,则先用2.0毫米球囊进行低压预扩张,然后再次尝试输送滤器。
研究人群包括80名男性和25名女性,年龄为73±10岁。SVG的平均使用年限为14±6年。92%的患者存在复杂病变(美国心脏病学会/美国心脏协会B2或C级)。105例患者中,82例(78.1%)FilterWire的初始输送成功。在最初输送失败的23例患者中,8例(35%)仅通过导丝辅助成功置入,7例(30%)通过球囊预扩张加导丝辅助成功置入,4例(17%)尽管采取了辅助操作但再次尝试置入仍失败,4例(17%)根据操作者的判断未进行额外的置入尝试。使用辅助输送技术后,置入失败率从最初的21.9%降至7.6%(P<0.01)。这些措施未观察到不良事件。
对于复杂的SVG病变,远端保护装置的置入在技术上可能困难。辅助输送技术对于优化SVG介入治疗期间远端保护滤器的置入成功率很重要。